Your browser doesn't support javascript.
loading
EASI p-EASI: Predicting Disease Severity in Patients with Atopic Dermatitis Treated with Tralokinumab.
Olydam, Jill I; de Wijs, Linde E M; Dik, Willem A; Røpke, Mads A; Da Rosa, Joel Correa; Hijnen, Dirk Jan.
Afiliação
  • Olydam JI; Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • de Wijs LEM; Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Dik WA; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
  • Røpke MA; Department of Clinical Pharmacology, LEO Pharma A/S, Ballerup, Denmark.
  • Da Rosa JC; Department of Biostatistics, The Rockefeller University Hospital, The Rockefeller University, New York, New York, USA.
  • Hijnen DJ; Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands. Electronic address: d.hijnen@erasmusmc.nl.
J Invest Dermatol ; 142(12): 3335-3337.e1, 2022 12.
Article em En | MEDLINE | ID: mdl-35843313
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatite Atópica Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatite Atópica Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article